To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies: Effectiveness, Safety, and Patterns of Use in Real-world Practice

RecruitingOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

August 5, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions
Infertility
Trial Locations (2)

100191

RECRUITING

Peking University Third Hospital (Beijing), Beijing

300052

RECRUITING

Tianjin Medical University General Hospital (Heping District), Xiaobailou

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY